论文信息 - MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials - 字舞流文

MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials

M. Gilbert | R. Stupp | M. Weller | T. Gorlia | O. Chinot | M. Hegi | L. Nabors | Greg Jones | J. Straub | W. van Criekinge | E. Genbrugge | L. Nabors | Mark R. Gilbert | Olivier L. Chinot | Greg Jones | Wim Van Criekinge | Josef Straub | Michael Weller | Mark R. Gilbert | Olivier L. Chinot | Greg Jones | Wim Van Criekinge | Josef Straub